Investors

Investor Information

The future of clinical development 
Evolving today’s best practices to meet tomorrow’s challenges.

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We are a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas. We strive to work as a trusted partner, guiding our customers through the ever-evolving landscape of clinical development so they can better achieve their business goals. 
We provide proactive insights and guidance across every phase of clinical research, helping our customers achieve their goals across a seamless delivery model spanning their product’s entire development cycle. Our comprehensive suite of integrated services and solutions strategically and proactively solve today’s challenges without losing sight of their impact tomorrow.

Share Price NASDAQ

Price

Change

High

Minimum 15 minutes delayed. Source: LSEG


Upcoming Events

July 30, 2026 at 8:00 AM EDT Q2 2026 Earnings Conference Call & Webcast

Upcoming Events

July 30, 2026 at 8:00 AM EDT

Q2 2026 Earnings Conference Call & Webcast


Investing in ICON

Learn more about which Industry Analysts cover ICON and other investment information.

Investing in ICON

Learn more about which Industry Analysts cover ICON and other investment information.



Search Investor